Optibiotix Health Share Discussion Threads

[primal123] 05/12/2017 07:07

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that subject to the completion of normal regulatory due diligence Neil Davidson CBE will be appointed as Non-Executive Chairman on 1 January 2018. Adam Reynolds, the current Non-Executive Chairman will step down on 31 December 2017. Neil brings to the Board over thirty years of operational and Board experience as Chairman and Chief Executive of FTSE 100, AIM, and private companies in both an executive and non-executive capacity. Neil has a wealth of commercial expertise in the food and retail sectors having started his career with Northern Foods plc, where he rose to become Managing Director of its milk division. He subsequently became Chief Executive of Express Dairies plc and then Arla Foods plc before taking on a number of Board positions in FTSE listed and private companies. Neil's experience in the public markets includes non-executive positions with a number of FTSE 100 companies such as Persimmons plc (£3.1bn revenue: 2016) from 2004-2013 and Wm Morrison Supermarkets (16.3bn revenue: 2016), where he is currently a Non-Executive Director. Neil was also Non-Executive Chairman of AIM quoted Produce Investments plc. Neil was awarded a CBE for services to the food and dairy industry in 2006. Neil has a personal interest in the development and commercialisation of technology to improve health. He was Chairman of Eminate, a spin out from the University of Nottingham which developed an alternative to salt which was licensed to Tate and Lyle, and Cherry Valley Farms, a genetics business which had extensive operations in China and the Far East, which was sold to an Asian private equity group in 2010. Neil has an extensive network of industry contacts and experience in sector specific M&A transactions. Stephen O'Hara, CEO of OptiBiotix, commented: "I am delighted to welcome Neil to the Board. He brings a unique mix of sector specific commercial expertise and a track record of building shareholder value. His network of contacts and wealth of experience on the Board of some of the UK's largest public companies will help guide OptiBiotix as it builds a microbiome business in what is forecast to be one of the world's fastest growth areas. The Board anticipates a future where microbiome products will be at the forefront of preventing, managing and treating many of today's chronic lifestyle disease and we hope under Neil's guidance OptiBiotix will continue to be one of the world's leaders in this exciting and emerging field. On behalf of the Board, I would like to thank Adam Reynolds, our outgoing interim Chairman, for his substantive contribution in helping guide OptiBiotix through its early developmental years. Adam has been an integral part of OptiBiotix's success and we wish him well in his future projects."

[onedayrodders] 04/12/2017 20:44

slarty ... maybe it was TW after all who mentioned some sort of pre xmas boosy

:O(

[primal123] 04/12/2017 20:24

Raf - I also think in time Opti will be huge, but it will take time! I do think we will get a couple of RNS' before Xmas but not sure if it will be the transformational news to push us out of this range! Let's wait and see!

[slartybartfaster] 04/12/2017 18:26

What promise rodders? As long as it wasnt tw making the promise.

[onedayrodders] 04/12/2017 17:08

were we not actually promised a sort of xmas present from SOH ?

[rafboy] 04/12/2017 17:00

Primal, I think we will have something before Xmas to give a lift to the share price Just a belief in SOH on my part. Not happy with the current share price myself but I do see 2018 as being a transformative year for OPTI.

[malreid] 04/12/2017 16:56

Added 3867 more at 67.8 - very overweight but confident

[judijudi] 04/12/2017 16:40

Well I never thought we would be at this shyte price again
Not even got any dry Gunpowder to take advantage of it :(

[primal123] 04/12/2017 16:35

Raf - yes I agree but the question is when it will arrive! We have been waiting a long time and have been stuck here for 2 years plus! I am still hoping we get something before Xmas but the Opti strategy is not to get an upfront payment, so most likely we will need to wait until financials come out to see the change! Unless as elrico says they have something up their sleeve!

[rathean] 04/12/2017 16:23

Just doubled up at 67.75, this will take off the moment a hint of revenues flows from the deals.

[rafboy] 04/12/2017 16:00

It will happen, far too many collaberations already for us to go down much more. Just need that bit of news that changes everything.

[primal123] 04/12/2017 15:54

Yes I agree JJ we do need something and we have been waiting a long time for us to break this trading range! It is very very frustrating to be back to the 60s again!

[primal123] 04/12/2017 15:22

OptiBiotix: Kellogg's move highlights the need for healthy alternative to sugar. Does one of AIM's innovators have the answer?Http://www.proactiveinvestors.co.uk/companies/news/188205/optibiotix-kelloggs-move-highlights-the-need-for-healthy-alternative-to-sugar-does-one-of-aims-innovators-have-the-answer-188205.html

[fathenry] 04/12/2017 15:14

hold fire boy

[fathenry] 04/12/2017 15:02

c lounge u are aving a go at guys onthe pyc bb, sameas ere judi stil sangria &got 12votes so not theonly one lounge am i ?

[elrico] 04/12/2017 14:53

JJ - That would be most welcome. IMHO we need a blockbuster announcement to get us shifting to nudge us to a 12 month high. Too many false dawns have been promised by we all know who. So the latest 100p by Christmas will have to fall into the category of blockbuster surprise nobody expected. Outside of that, we are left with similar news items related to commercial contracts for LP-LDL, SlimBiome...SweetBiotx? New Year campaign for the launch of new improved SlimBiome products. Then we have April to look for clues within the YE17...of which there will be no TATA revenues data until interims later in the year, if my grey matter remembers correctly.

[riskybusiness1] 04/12/2017 14:26

Bob please tell us how much of that £650k Opti put into Skin before its IPO has been depleted.... Have a day off.

[bobalot] 04/12/2017 14:16

THIS STOCK IS PROPED UP WITH HYPE.

Every time a spin off happens the value of OPTI gets depleted.

Better to buy into the spin offs imo.


1bokke 4 Dec '17 - 12:03 - 29750 of 29752 5 0

People like you and the OPTI MOB get more ridiculous everyday --- divisive and delutional -- I deal in facts not false statements designed to mislead the public....try it.

[judijudi] 04/12/2017 13:55

Dear Mr O'Hara,
We've all had plenty of time to load up at these throw away prices
I think its about time that you now released the brakes! :)

[bobalot] 04/12/2017 10:04

OPTI own just 41% they need 50% to call SBTX a subsidiary and 52% to have a controlling interest and majority shareholding.

plenty of the OPTI MOB have said SBTX is a subsidiary including a couple of resident gurus...so you are wrong...the evidence says otherwise dipstick.


People like you are so thick.

[1bokke] 04/12/2017 09:24

Bob I did warn you about exposing your stupidity to a wider audience. All Opti shareholders hope that Skinbio will be successful and the reason is that if it is then we will benefit, however there is no getting away from the fact that Skinbio is still a riskier play. They have 3 stated areas of interest and according to their website all three are still at the pre clinical stage. Why would you expect people to move money from a company that has started commercialising some products and is now on a growth curve to a company that cannot yet guarantee that it's products will pass the clinical phase? You are clearly desperate for a short term upsurge in Skinbio and that should make people wary of your advice and opinions.Calling out Elrico( or anyone for that matter) as a conman and a liar without a shred of evidence to back it up is stupid. Your repeated assertion of the fact that SBTX is not a sub of Opti is an example of your limited intellect because nobody has said that it currently is a sub so you are lecturing to people that actually agree with your position on this!! As I've said before you owe an apology.

[riskybusiness1] 04/12/2017 08:34

VRS is very exciting. Looking to build there on dips. Took a punt a while back should have put down more.Opti time will come I'm very confident of that. If Opti goes below 65 I will take one last chunk. Everything is building very nicely here and results YE 2018 should either see Opti profitable or as close as damn it which will see the long awaited transformation if not before.Bobalot if SOH was boss of SKIN you may have a point however it would be rather stupid to move my Opti holding across to Skin seeing as I will benefit through its growth and/or share distribution anyway. One of the main reasons Opti span out Skin was because it was a significant risk and if it failed would have risked severely impacting Opti.